| Product NDC: | 58118-1117 |
| Proprietary Name: | Mirtazapine |
| Non Proprietary Name: | Mirtazapine |
| Active Ingredient(s): | 15 mg/1 & nbsp; Mirtazapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58118-1117 |
| Labeler Name: | Clinical Solutions Wholesale |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076312 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030619 |
| Package NDC: | 58118-1117-0 |
| Package Description: | 1 TABLET, FILM COATED in 1 PACKET (58118-1117-0) |
| NDC Code | 58118-1117-0 |
| Proprietary Name | Mirtazapine |
| Package Description | 1 TABLET, FILM COATED in 1 PACKET (58118-1117-0) |
| Product NDC | 58118-1117 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mirtazapine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20030619 |
| Marketing Category Name | ANDA |
| Labeler Name | Clinical Solutions Wholesale |
| Substance Name | MIRTAZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |